Global Rabies Diagnostics Market, By Diagnostic Method (Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests), Technology (ELISA/Immunohistochemistry, Chromatography Techniques, PCR, Others), End-Users (Hospital, Diagnostic Centers, Cancer Palliative Care Clinics, Pharmacies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights Global Rabies Diagnostics Market
Data Bridge Market Research analyses that the rabies diagnostics market to be grow at a CAGR of 4.62% in the forecast period of 2022-2029 and is likely to reach the USD 2.40 billion by 2029.
Rabies is an acute viral infection that usually affects the nervous system. They are caused mostly by rhabdovirus, which is transmitted primarily through the bite of a rabid animal. The presence of rabies viral antigens in brain tissue can be detected using a direct fluorescent antibody (DFA) test, which can be used to diagnose rabies in animals. In humans, a variety of tests are required.
The rising cases of neglected tropical diseases (NTDs) will act as major driver accelerating the rabies diagnostics market’s growth rate. The rising cases of dog bites will increase the incidences of rabies and further propel the market’s growth rate. Another significant factor resulting in the expansion of market is the rise in number of laws linked with diagnosis of rabies. Furthermore, surging healthcare expenditure and increasing awareness among population about the risk of virus exposure are the major drivers that will enhance the growth of market. Likewise, advancement in technology associated with diagnosis and launch of new products will show positive impact on the market’s growth rate. Rapid urbanisation, changing lifestyle and rise in the level of disposable incomes in developing and developed countries will influence the growth rate of rabies diagnostics market.
Moreover, the rise in the collaborations among organizations for the development of novel products and rise in the research to control rabies will provide beneficial opportunities for the rabies diagnostics market growth. Additionally, the increasing demand from emerging markets and the rise in government initiatives will further expand the rabies diagnostics market’s growth rate in the future.
On the other hand, high cost associated with diagnostic and increasing vaccination will obstruct the market growth. Also, intense competition among market players and negative impact of COVID-19 on supply chain will challenge the rabies diagnostics market. However, the dearth of awareness will act as restrain and further impede the growth rate of market.
This rabies diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on rabies diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Rabies Diagnostics Market Scope and Market Size
The rabies diagnostics market is segmented on the basis of diagnostic method, technology and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on diagnostic method, the rabies diagnostic market is segmented into fluorescent antibody test, immunohistochemical test, amplification methods, histologic examination, and serology tests.
- Rabies diagnostic market on the basis of technology is categorized into ELISA/immunohistochemistry, chromatography techniques, PCR and others.
- Rabies diagnostics market is also categorized on the basis of end-users. The end- user segment is further categorized into hospital, diagnostic centers, cancer palliative care clinics, and pharmacies.
Rabies Diagnostics Market Country Level Analysis
The rabies diagnostics market is analysed and market size insights and trends are provided by country, diagnostic method, technology and end-users as referenced above.
The countries covered in the rabies diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the rabies diagnostics market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and rising cases of rabies in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the growing involvement of many non-profit organizations to control the disease in this region.
The country section of the rabies diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The rabies diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for rabies diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the rabies diagnostics market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Global Rabies Diagnostics Market Share Analysis
The rabies diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to rabies diagnostics market.
Some of the major players operating in the rabies diagnostics market are Bio-Rad Laboratories, Inc., Merck KGaA, Aviva Systems Biology Corporation, Creative Diagnostics., MyBioSource, Demeditec Diagnostics GmbH, Abbexa Ltd, Norgen Biotek Corp., and Express Biotech International, among others.
SKU-